A RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY AND IMMUNOTHERAPY IN CUTANEOUS MELANOMA

被引：226

作者：

VERONESI, U

ADAMUS, J

AUBERT, C

BAJETTA, E

BERETTA, G

BONADONNA, G

BUFALINO, R

CASCINELLI, N

COCCONI, G

DURAND, J

DEMARSILLAC, J

IKONOPISOV, RL

KISS, B

LEJEUNE, F

MACKIE, R

MADEJ, G

MULDER, H

MECHL, Z

MILTON, GW

MORABITO, A

PETER, H

PRIARIO, J

PAUL, E

RUMKE, P

SERTOLI, R

TOMIN, R

机构：

[1] IST NAZL TUMORI,VIA VENEZIAN 1,I-20133 MILAN,ITALY

[2] HANOVER UNIV MED,KLIN IMMUNOL ABT,D-3000 HANOVER 61,FED REP GER

[3] ABT KLIN & EXPTL DERMATOL,GIESSEN,FED REP GER

[4] OSPED RIUNITI,CTR MED ONCOL,PARMA,ITALY

[5] FDN CURIE,F-75231 PARIS 05,FRANCE

[6] HET NEDERLANDS KANKERINST,AMSTERDAM,NETHERLANDS

[7] HOSP CLIN M QUINTELA,MONTEVIDEO,URUGUAY

[8] INST ONCOL,BELGRADE,YUGOSLAVIA

[9] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM

[10] INST NACL CANC,RIO DE JANEIRO,BRAZIL

[11] INST J PAOLI I CALMETTES,F-13009 MARSEILLE,FRANCE

[12] IST ONCOL,GENOA,ITALY

[13] IST NAZL STUDIO & CURA TUMORI,MILAN,ITALY

[14] ONCOL INST,BRNO,CZECHOSLOVAKIA

[15] INST ONCOL,PL-44100 GLIWICE,POLAND

[16] ONCOL RES INST,SOFIA,BULGARIA

[17] INST ONCOL,PL-02034 WARSAW,POLAND

[18] ROTTERDAMSCH RADIOTHERAPEUT INST,ROTTERDAM,NETHERLANDS

[19] SYDNEY HOSP,SYDNEY,NSW 2000,AUSTRALIA

[20] STATE INST ONCOL,BUDAPEST,HUNGARY

[21] UNIV GLASGOW,DEPT DERMATOL,GLASGOW G12 8QQ,SCOTLAND

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1982年 / 307卷 / 15期

关键词：

D O I：

10.1056/NEJM198210073071503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：913 / 916

页数：4

共 21 条

[1] BCG IMMUNOTHERAPY OF LOCAL SUBCUTANEOUS GROWTHS AND POST-SURGICAL PULMONARY METASTASES OF A TRANSPLANTED RAT EPITHELIOMA OF SPONTANEOUS ORIGIN [J].

BALDWIN, RW ;

PIMM, MV .

INTERNATIONAL JOURNAL OF CANCER, 1973, 12 (02) :420-427

[2]

BANZET P, 1978, CANCER, V41, P1240, DOI 10.1002/1097-0142(197804)41:4<1240::AID-CNCR2820410404>3.0.CO

[3]

2-J

[4]

GUTTERMAN JU, 1973, LANCET, V1, P1208

[5] SPECIFIC ACTIVE IMMUNOTHERAPY DOES NOT PROLONG SURVIVAL IN SURGICALLY TREATED PATIENTS WITH STAGE 2B MALIGNANT-MELANOMA AND MAY PROMOTE EARLY RECURRENCE [J].

HEDLEY, DW ;

MCELWAIN, TJ ;

CURRIE, GA .

BRITISH JOURNAL OF CANCER, 1978, 37 (04) :491-496

[6]

HILL GJ, 1981, CANCER-AM CANCER SOC, V47, P2556, DOI 10.1002/1097-0142(19810601)47:11<2556::AID-CNCR2820471107>3.0.CO

[7]

2-J

[8]

JACQUILLAT C, 1979, RECENT RES CANCER, V68, P346

[9] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[10] RELATIONSHIP OF IMMUNE STATUS TO EFFICACY OF IMMUNOTHERAPY IN PREVENTING TUMOR RECURRENCE IN MICE [J].

LEVY, JG ;

WHITNEY, RB ;

SMITH, AG ;

PANNO, L .

BRITISH JOURNAL OF CANCER, 1974, 30 (04) :289-296

← 1 2 3 →